Jayne Dixon Weber and Dr. Craig Erickson discuss new medications and review existing medications used for various issues related to Fragile X syndrome.
Craig Erickson, MD
Dr. Erickson is a noted Fragile X expert and the medical director of the Fragile X Syndrome Research and Treatment Center in Cincinnati, Ohio. He is a friend of the NFXF and shares his knowledge on Fragile X and medical advice on a regular basis.
Dr. Erickson has worked to obtain continuous federal, foundation, internal, and industry funding to support his and his collaborators’ research over the last 10+ years of his career. He is the inventor or co-inventor of many patents focused on translational treatment development in neurodevelopment disorders held at Cincinnati Children’s Hospital Medical Center and previously at Indiana University School of Medicine. He is considered an international expert in the clinical treatment of Fragile X syndrome and has similar expertise in Fragile X-specific clinical trial development. Additionally, Dr. Erickson is an avid teacher of future generations of child psychiatrists and has received several teaching awards for his work.